Home Business & Economics

Business & Economics

Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

Immunomedics Resubmits BLA for Sacituzumab Govitecan

In a statement earlier today, Immunomedics confirmed that the company resubmitted its Biologics License Application (BLA) to the U.S....

ADC Express: Rapid ADC Production from a Single Source

Earlier this year, during the 10th annual World ADC meeting held in San Diego, CA, MilliporeSigma, launched a new...

SOTIO and NBE-Therapeutics to Develop ‘Second’ Next-Generation Antibody-Drug Conjugate

SOTIO, a biotechnology company leading the efforts of PPF Group, one of the largest investment groups in Central and...
Daiichi Sankyo

Daiichi Sankyo to Defend Proprietary Antibody-drug Conjugate Technology

Daiichi Sankyo confirmed that the company has filed a Declaratory Judgement action in the District Court of Delaware in...
Signing Ceremony between Ambrx an NovoCodex. Courtesy 2019 NovoCodex.

Ambrx and Novocodex to Jointly Develop and Commercialize 2nd Antibody-drug Conjugate

Novocodex Biopharmaceuticals, a subsidiary of Zhejiang Medicine, and  Ambrx, a privately-held clinical stage biopharmaceutical company, have confirmed that the...

Immunome and pH Pharma Sign Agreement for the Development of Novel ADCs

South Korea-based pH Pharma, a clinical stage biopharmaceutical company and U.S.-based Immunome, a biotechnology company developing first-in-class antibodies as...
On October 16, 2019 Novocodex Biopharmaceuticals, a subsidiary of Zhejiang Medicine, and WuXi Biologics signed a strategic partnership for Phase III clinical trial production of ARX788 as well ongoing large-scale commercial production of the innovative antibody-drug conjugate.

WuXi Biologics Opens New Facility to Supports Novocodex ADC Manufacturing

Earlier this month China-based Contract Research Organization (CRO) WuXi Biologics started commercial production at the company's new Current Good...

Innate Pharma Confirms Securing Investment to Develop Novel ADC

The French biotechnology company Innate Pharma, which focuses on the discovery as well as the development and commercialization of...
Featured Image - Laboratory. Courtesy 2019 Fotolia

Study Demonstrates Superior Efficacy and Cytotoxicity of Femtogenix’s Sequence-selective DNA-interactive Payload

Data verifying a favorable toxicity profile and potent efficacy of a novel pyrridinobenzodiazepine (PDD) antibody-drug conjugate payload platform in...
MabPlex Building

Frost & Sullivan Awards MabPlex with the 2019 Global Growth Excellence Leadership Award

Based on its recent analysis of the global contract manufacturing services market for antibody-drug conjugate or ADCs, Frost &...